Global Infectious Disease Diagnostics Market Overview:
Global Infectious Disease Diagnostics Market Is Expected to Grow at A Significant Growth Rate, And the Forecast Period Is 2026-2035, Considering the Base Year As 2025.
Global Infectious Disease Diagnostics Market Report 2026 comes with the extensive industry analysis with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2026-2035, with base year as 2025. This research study of Infectious Disease Diagnostics involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Infectious Disease Diagnostics Market:
The Infectious Disease Diagnostics Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for Infectious Disease Diagnostics Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Infectious Disease Diagnostics Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, Infectious Disease Diagnostics market has been segmented into:
Assays & Reagents
Instruments
Software
By Application, Infectious Disease Diagnostics market has been segmented into:
Immunodiagnostics
Clinical Microbiology
PCR
INAAT
DNA Sequencing & NGS
DNA Microarray
Other Technologies).
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Infectious Disease Diagnostics market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Infectious Disease Diagnostics market.
Top Key Players Covered in Infectious Disease Diagnostics market are:
Abbott Laboratories
Becton
Dickinson and Company
bioMerieux SA
Bio-Rad Laboratories Inc.
Danaher Corporation
DiaSorin SpA
Luminex Corporation
Meridian Bioscience Inc.
Quidel Corporation
Roche Diagnostics (Schweiz) AG
Siemens AG
Thermo Fisher Scientific Inc.
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Industry Dynamics and Opportunity Analysis
3.1.1 Growth Drivers
3.1.2 Limiting Factors
3.1.3 Growth Opportunities
3.1.4 Challenges and Risks
3.2 Market Trend Analysis
3.3 Strategic Pestle Overview
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Mapping
3.6 Regulatory Framework
3.7 Princing Trend Analysis
3.8 Patent Analysis
3.9 Technology Evolution
3.10 Investment Pockets
3.11 Import-Export Analysis
Chapter 4: Infectious Disease Diagnostics Market Type
4.1 Infectious Disease Diagnostics Market Snapshot and Growth Engine
4.2 Infectious Disease Diagnostics Market Overview
4.3 Assays & Reagents
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.3.3 Assays & Reagents: Geographic Segmentation Analysis
4.4 Instruments
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.4.3 Instruments: Geographic Segmentation Analysis
4.5 Software
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.5.3 Software: Geographic Segmentation Analysis
Chapter 5: Infectious Disease Diagnostics Market Application
5.1 Infectious Disease Diagnostics Market Snapshot and Growth Engine
5.2 Infectious Disease Diagnostics Market Overview
5.3 Immunodiagnostics
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.3.3 Immunodiagnostics: Geographic Segmentation Analysis
5.4 Clinical Microbiology
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.4.3 Clinical Microbiology: Geographic Segmentation Analysis
5.5 PCR
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.5.3 PCR: Geographic Segmentation Analysis
5.6 INAAT
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.6.3 INAAT: Geographic Segmentation Analysis
5.7 DNA Sequencing & NGS
5.7.1 Introduction and Market Overview
5.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.7.3 DNA Sequencing & NGS: Geographic Segmentation Analysis
5.8 DNA Microarray
5.8.1 Introduction and Market Overview
5.8.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.8.3 DNA Microarray: Geographic Segmentation Analysis
5.9 Other Technologies).
5.9.1 Introduction and Market Overview
5.9.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.9.3 Other Technologies).: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Infectious Disease Diagnostics Market Share by Manufacturer (2025)
6.1.3 Concentration Ratio(CR5)
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 ABBOTT LABORATORIES; BECTON
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Operating Business Segments
6.2.5 Product Portfolio
6.2.6 Business Performance
6.2.7 Key Strategic Moves and Recent Developments
6.3 DICKINSON AND COMPANY; BIOMERIEUX SA; BIO-RAD LABORATORIES
6.4 INC.; DANAHER CORPORATION; DIASORIN SPA; LUMINEX CORPORATION; MERIDIAN BIOSCIENCE
6.5 INC.; QUIDEL CORPORATION; ROCHE DIAGNOSTICS (SCHWEIZ) AG; SIEMENS AG; THERMO FISHER SCIENTIFIC
6.6 INC.
Chapter 7: Global Infectious Disease Diagnostics Market By Region
7.1 Overview
7.2. North America Infectious Disease Diagnostics Market
7.2.1 Historic and Forecasted Market Size by Segments
7.2.2 Historic and Forecasted Market Size By Type
7.2.2.1 Assays & Reagents
7.2.2.2 Instruments
7.2.2.3 Software
7.2.3 Historic and Forecasted Market Size By Application
7.2.3.1 Immunodiagnostics
7.2.3.2 Clinical Microbiology
7.2.3.3 PCR
7.2.3.4 INAAT
7.2.3.5 DNA Sequencing & NGS
7.2.3.6 DNA Microarray
7.2.3.7 Other Technologies).
7.2.4 Historic and Forecast Market Size by Country
7.2.4.1 US
7.2.4.2 Canada
7.2.4.3 Mexico
7.3. Eastern Europe Infectious Disease Diagnostics Market
7.3.1 Historic and Forecasted Market Size by Segments
7.3.2 Historic and Forecasted Market Size By Type
7.3.2.1 Assays & Reagents
7.3.2.2 Instruments
7.3.2.3 Software
7.3.3 Historic and Forecasted Market Size By Application
7.3.3.1 Immunodiagnostics
7.3.3.2 Clinical Microbiology
7.3.3.3 PCR
7.3.3.4 INAAT
7.3.3.5 DNA Sequencing & NGS
7.3.3.6 DNA Microarray
7.3.3.7 Other Technologies).
7.3.4 Historic and Forecast Market Size by Country
7.3.4.1 Russia
7.3.4.2 Bulgaria
7.3.4.3 The Czech Republic
7.3.4.4 Hungary
7.3.4.5 Poland
7.3.4.6 Romania
7.3.4.7 Rest of Eastern Europe
7.4. Western Europe Infectious Disease Diagnostics Market
7.4.1 Historic and Forecasted Market Size by Segments
7.4.2 Historic and Forecasted Market Size By Type
7.4.2.1 Assays & Reagents
7.4.2.2 Instruments
7.4.2.3 Software
7.4.3 Historic and Forecasted Market Size By Application
7.4.3.1 Immunodiagnostics
7.4.3.2 Clinical Microbiology
7.4.3.3 PCR
7.4.3.4 INAAT
7.4.3.5 DNA Sequencing & NGS
7.4.3.6 DNA Microarray
7.4.3.7 Other Technologies).
7.4.4 Historic and Forecast Market Size by Country
7.4.4.1 Germany
7.4.4.2 UK
7.4.4.3 France
7.4.4.4 The Netherlands
7.4.4.5 Italy
7.4.4.6 Spain
7.4.4.7 Rest of Western Europe
7.5. Asia Pacific Infectious Disease Diagnostics Market
7.5.1 Historic and Forecasted Market Size by Segments
7.5.2 Historic and Forecasted Market Size By Type
7.5.2.1 Assays & Reagents
7.5.2.2 Instruments
7.5.2.3 Software
7.5.3 Historic and Forecasted Market Size By Application
7.5.3.1 Immunodiagnostics
7.5.3.2 Clinical Microbiology
7.5.3.3 PCR
7.5.3.4 INAAT
7.5.3.5 DNA Sequencing & NGS
7.5.3.6 DNA Microarray
7.5.3.7 Other Technologies).
7.5.4 Historic and Forecast Market Size by Country
7.5.4.1 China
7.5.4.2 India
7.5.4.3 Japan
7.5.4.4 South Korea
7.5.4.5 Malaysia
7.5.4.6 Thailand
7.5.4.7 Vietnam
7.5.4.8 The Philippines
7.5.4.9 Australia
7.5.4.10 New Zealand
7.5.4.11 Rest of APAC
7.6. Middle East & Africa Infectious Disease Diagnostics Market
7.6.1 Historic and Forecasted Market Size by Segments
7.6.2 Historic and Forecasted Market Size By Type
7.6.2.1 Assays & Reagents
7.6.2.2 Instruments
7.6.2.3 Software
7.6.3 Historic and Forecasted Market Size By Application
7.6.3.1 Immunodiagnostics
7.6.3.2 Clinical Microbiology
7.6.3.3 PCR
7.6.3.4 INAAT
7.6.3.5 DNA Sequencing & NGS
7.6.3.6 DNA Microarray
7.6.3.7 Other Technologies).
7.6.4 Historic and Forecast Market Size by Country
7.6.4.1 Turkiye
7.6.4.2 Bahrain
7.6.4.3 Kuwait
7.6.4.4 Saudi Arabia
7.6.4.5 Qatar
7.6.4.6 UAE
7.6.4.7 Israel
7.6.4.8 South Africa
7.7. South America Infectious Disease Diagnostics Market
7.7.1 Historic and Forecasted Market Size by Segments
7.7.2 Historic and Forecasted Market Size By Type
7.7.2.1 Assays & Reagents
7.7.2.2 Instruments
7.7.2.3 Software
7.7.3 Historic and Forecasted Market Size By Application
7.7.3.1 Immunodiagnostics
7.7.3.2 Clinical Microbiology
7.7.3.3 PCR
7.7.3.4 INAAT
7.7.3.5 DNA Sequencing & NGS
7.7.3.6 DNA Microarray
7.7.3.7 Other Technologies).
7.7.4 Historic and Forecast Market Size by Country
7.7.4.1 Brazil
7.7.4.2 Argentina
7.7.4.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Infectious Disease Diagnostics Scope:
|
Report Data
|
Infectious Disease Diagnostics Market
|
|
Infectious Disease Diagnostics Market Size in 2025
|
USD XX million
|
|
Infectious Disease Diagnostics CAGR 2025 - 2032
|
XX%
|
|
Infectious Disease Diagnostics Base Year
|
2024
|
|
Infectious Disease Diagnostics Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Abbott Laboratories, Becton, Dickinson and Company, bioMerieux SA, Bio-Rad Laboratories Inc., Danaher Corporation, DiaSorin SpA, Luminex Corporation, Meridian Bioscience Inc., Quidel Corporation, Roche Diagnostics (Schweiz) AG, Siemens AG, Thermo Fisher Scientific Inc..
|
|
Key Segments
|
By Type
Assays & Reagents
Instruments
Software
By Applications
Immunodiagnostics
Clinical Microbiology
PCR
INAAT
DNA Sequencing & NGS
DNA Microarray
Other Technologies).
|
